Virovet
Bart Crijns has worked in the finance and accounting industry since 1999. Bart began their career at EMC as a Senior Accountant Belux. In 2006, they joined CSL Behring as a Controller & Finance Manager and Senior Accountant Benelux. In 2013, they moved to Okapi Sciences as a Finance Manager and also worked as an Accounting & Business Administration Officer at JSR Micro. From 2014 to 2017, they were a Finance Manager at Aratana Therapeutics NV. In 2018, they became the Director Finance at ViroVet.
Bart Crijns obtained a Bachelor in Accountancy-Fiscaliteit from Bedrijfsbeheer, Accountancy-Fiscaliteit, Departement Economische Hogeschool Heilig Hart Heverlee between 1996 and 1999.
Virovet
ViroVet is a pioneering company dedicated to the development of disruptive and innovative technologies for the control of viral diseases in livestock, with antiviral drugs (video) for respiratory disease complexes and innovative vaccines (video) for viral infections in swine leading the pipeline.